BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17328071)

  • 21. [Anti-ribosomal antibodies as activity markers in systemic lupus erythematosus].
    Almeida D; Antolín J; Amérigo MJ; Cantabrana A; Roces A; Hayeck M
    An Med Interna; 2002 Feb; 19(2):73-5. PubMed ID: 11989101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
    Hoffman IE; Lauwerys BR; De Keyser F; Huizinga TW; Isenberg D; Cebecauer L; Dehoorne J; Joos R; Hendrickx G; Houssiau F; Elewaut D
    Ann Rheum Dis; 2009 Mar; 68(3):412-5. PubMed ID: 18930995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression.
    Ago Y; Arikawa S; Yata M; Yano K; Abe M; Takuma K; Matsuda T
    Neuropharmacology; 2008 Dec; 55(8):1355-63. PubMed ID: 18796307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus.
    Harrison MJ; Ravdin LD; Lockshin MD
    Arthritis Rheum; 2006 Aug; 54(8):2515-22. PubMed ID: 16868972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The therapeutic potential of targeting anti-Ribosomal-P antibody in treating SLE patients with depression.
    Blank M; Beinglass I; Shoenfeld Y
    Expert Opin Biol Ther; 2007 Sep; 7(9):1283-5. PubMed ID: 17727319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human parvovirus B19 VP1 unique region protein.
    Tzang BS; Lee YJ; Yang TP; Tsay GJ; Shi JY; Tsai CC; Hsu TC
    Clin Chim Acta; 2007 Jul; 382(1-2):31-6. PubMed ID: 17451664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antidepressant-like effects of the ethanolic extract of Xiaobuxin-Tang, a traditional Chinese herbal prescription in animal models of depression.
    Zhang YZ; Li YF; Yu NJ; Yuan L; Zhao YM; Xiao WB; Luo ZP
    Chin Med J (Engl); 2007 Oct; 120(20):1792-6. PubMed ID: 18028773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidepressant-mediated reversal of abnormal behavior and neurodegeneration in mice following olfactory bulbectomy.
    Jarosik J; Legutko B; Unsicker K; von Bohlen Und Halbach O
    Exp Neurol; 2007 Mar; 204(1):20-8. PubMed ID: 17059819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibodies to the ribosomal P proteins in systemic lupus erythematosus.
    Reichlin M
    Clin Exp Med; 2006 Jun; 6(2):49-52. PubMed ID: 16820990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Humoral antigenic targets of the ribosomal P0 lupus autoantigen are not limited to the carboxyl region.
    Bruner BF; Wynn DM; Reichlin M; Harley JB; James JA
    Ann N Y Acad Sci; 2005 Jun; 1051():390-403. PubMed ID: 16126981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: possible involvement of alpha-2 adrenergic receptors.
    Dhir A; Kulkarni SK
    Neurosci Lett; 2008 Nov; 445(1):83-8. PubMed ID: 18778754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice.
    Wen ZK; Xu W; Xu L; Cao QH; Wang Y; Chu YW; Xiong SD
    Rheumatology (Oxford); 2007 Dec; 46(12):1796-803. PubMed ID: 18032537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential antidepressants: pharmacology of 2-(4-methyl piperazin-1-yl)-1,8-naphthyridine-3-carbonitrile in rodent behavioural models.
    Mahesh R; Rajkumar R; Minasri B; Venkatesha Perumal R
    Pharmazie; 2007 Dec; 62(12):919-24. PubMed ID: 18214343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spatial and motor abilities during the course of autoimmune disease in (NZW x BXSB)F1 lupus-prone mice.
    Arabo A; Costa O; Tron F; Caston J
    Behav Brain Res; 2005 Nov; 165(1):126-37. PubMed ID: 16168499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding.
    Sugimoto Y; Kajiwara Y; Hirano K; Yamada S; Tagawa N; Kobayashi Y; Hotta Y; Yamada J
    Eur J Pharmacol; 2008 Sep; 592(1-3):116-22. PubMed ID: 18655786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
    Dhir A; Kulkarni SK
    Eur J Pharmacol; 2007 Jul; 568(1-3):177-85. PubMed ID: 17509558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis.
    Karassa FB; Afeltra A; Ambrozic A; Chang DM; De Keyser F; Doria A; Galeazzi M; Hirohata S; Hoffman IE; Inanc M; Massardo L; Mathieu A; Mok CC; Morozzi G; Sanna G; Spindler AJ; Tzioufas AG; Yoshio T; Ioannidis JP
    Arthritis Rheum; 2006 Jan; 54(1):312-24. PubMed ID: 16385548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral abnormality and pharmacologic response in social isolation-reared mice.
    Koike H; Ibi D; Mizoguchi H; Nagai T; Nitta A; Takuma K; Nabeshima T; Yoneda Y; Yamada K
    Behav Brain Res; 2009 Aug; 202(1):114-21. PubMed ID: 19447287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
    Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
    Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.